Found 14 clinical trials
Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
- 0 views
- 17 Feb, 2022
- 1 location
Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis
oral Gemifloxacin versus intravenous Cefotaxime in treatment of spontaneous bacterial peritonitis
- 0 views
- 18 Feb, 2022
- 1 location
Primary Antibiotic Prophylaxis Using Co-trimoxazole to Prevent Spontaneous Bacterial Peritonitis in Cirrhosis
bacterial peritonitis to improve overall survival
- 0 views
- 16 Oct, 2021
- 1 location
Ascitic Fluid Calprotectin as an Accurate Diagnostic Marker for Spontaneous Bacterial Peritonitis
Spontaneous bacterial peritonitis (SBP) is an infection of the ascitic fluid in patients with liver cirrhosis and portal hypertension. There is no obvious surgical cause as perforation or
- 0 views
- 27 Jun, 2022
- 1 location
Primary Prophylaxis for Spontaneous Bacterial Peritonitis
perpetuating decompensation and spontaneous bacterial peritonitis. We hypothesise that cirrhosis patients with concomitant SIBO are particularly vulnerable for endotoxin translocation and would benefit from
- 0 views
- 10 Mar, 2021
- 1 location
Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
The aim of the study is to compare the effectiveness of rifaximin versus norfloxacin for secondary prevention of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites
- 9 views
- 22 Jan, 2021
- 1 location
EUS Guided Portal-systemic Pressure Gradient Measurement
bleeding, ascites, spontaneous bacterial peritonitis, hepatic encephalopathy and mortality. Albeit its clinical significance, direct measurement of portal venous pressure to document portal
- 0 views
- 06 Dec, 2021
- 1 location
Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices
the risk of developing spontaneous bacterial peritonitis.
- 0 views
- 06 Nov, 2021
- 1 location
Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind Placebo-controlled Trial
use in cirrhotic patients may be a risk factor for the development of infections, especially spontaneous bacterial peritonitis (SBP). A possible explanation are PPI-associated microbiotic shifts
- 0 views
- 14 May, 2021
- 1 location
Growth Hormone in Decompensated Liver Cirrhosis
Globally, cirrhosis and liver cancer carries a huge burden and accounts for about 3.5% (2 million) of all deaths every year. Once decompensated, i.e. development of ascites, variceal bleed, encephalopathy, and jaundice, the life expectancy is markedly reduced to a median of two years. The definitive treatment in this stage, …
- 0 views
- 23 Apr, 2022
- 1 location
- 1
- 2